These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14412384)

  • 21. [Demonstration of sporadic isoniazid-sensitive colonies in a primarily isoniazid-resistant culture with the aid of peroxidase tests].
    VISCHER WA; TIRUNARAYANAN MO; BRUHIN H
    Schweiz Z Tuberc Pneumonol; 1959; 16():415-8. PubMed ID: 13842454
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of isoniazid on the synthesis of certain amino acids and vitamins by Mycobacterium tuberculosis.
    WILLETT HP
    Am Rev Respir Dis; 1959 Sep; 80():404-9. PubMed ID: 13844810
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations on the Welsch phenomenon in the course of research conducted on various strains of M. tuberculosis].
    CHIGNOLI V
    Acta Med Ital Mal Infett Parassit; 1960; 15():133-8. PubMed ID: 13878955
    [No Abstract]   [Full Text] [Related]  

  • 24. Activity of niamid tuberculosis and cross resistance to isonizid.
    KLUGH GA; PRATT PC; ATWELL RJ
    Am J Psychiatry; 1960 Sep; 117():269-70. PubMed ID: 14410010
    [No Abstract]   [Full Text] [Related]  

  • 25. [Attempts at differentiating Mycobacteria according to the sensitivity of their catalase activity to inhibitors].
    ANDREJEW A; GERNEZ-RIEUX C
    Ann Inst Pasteur (Paris); 1962 Aug; 103():201-15. PubMed ID: 13861444
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of the mechanism of appearance of INH resistance. I. The isolation of INH-resistant strains which require certain growth-supporting factors and these supporting factors].
    KOGA T
    Kekkaku; 1960 Feb; 35():113-7. PubMed ID: 14410498
    [No Abstract]   [Full Text] [Related]  

  • 27. [The characteristic resistance of Mycobacterium and its role played in the development of acquired resistance to antituberculous agents. 4. Natural resistance to SM and INH and the development of acquired resistance].
    YAMADA O
    Kekkaku; 1959 Dec; 34():823-9. PubMed ID: 13846375
    [No Abstract]   [Full Text] [Related]  

  • 28. [On certain immuno-biological characteristics of INH-resistant strains].
    GARBINSKI T
    Gruzlica (1926); 1959 Jul; 27():653-7. PubMed ID: 13826384
    [No Abstract]   [Full Text] [Related]  

  • 29. [The characteristic resistance of mycobacteria and its role played in the development of acquired resistance to antituberculous agents. 5. Resistance to SM and INH of the cells in the suspensions of mycobacteria and the development of the acquired resistance in these cells].
    YAMADA O
    Kekkaku; 1960 Jan; 35():1-5. PubMed ID: 13846378
    [No Abstract]   [Full Text] [Related]  

  • 30. Tubercle bacillus antibiogram with respect to technique.
    LORIAN V
    Acta Tuberc Scand; 1960; 39():222-4. PubMed ID: 13763546
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriotropic activity of isoniazid in the presence of certain other compounds.
    URBANCIK R
    Am Rev Tuberc; 1958 Nov; 78(5):802-5. PubMed ID: 13583449
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new method of examining the bacteriostatic effect of INH in microbiological assay for INH concentration in human serum].
    YAMAMOTO Y; SAKAMOTO Y
    Kekkaku; 1961 Feb; 36():88-93. PubMed ID: 13787160
    [No Abstract]   [Full Text] [Related]  

  • 33. The properties of para-aminosalicylic acid-resistant Mycobacterium tuberculosis var. hominis.
    TSUKAMURA M
    Am Rev Tuberc; 1957 Apr; 75(4):608-17. PubMed ID: 13411418
    [No Abstract]   [Full Text] [Related]  

  • 34. [In vitro effect of PAB on Mycobacterium tuberculosis and M. paratuberculosis].
    NITTI V
    Boll Soc Ital Biol Sper; 1951 Dec; 27(12):1681-8. PubMed ID: 14934920
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of isoniazid-resistant tubercle bacilli. I. On the population change of isoniazid-resistant tubercle bacilli as regards their resistance to isoniazid].
    NAGASHIMA M
    Kekkaku; 1960 Dec; 35():861-7. PubMed ID: 13727413
    [No Abstract]   [Full Text] [Related]  

  • 36. [Structure of INH-resistant variants of the BCG-Paris strain. Isolation, culture and production of INH-resistant catalase-positive and catalase-negative mutants with a view toward vaccination].
    AUGIER J; BRETEY J; KOSLOFF-SENECHAL F
    Ann Inst Pasteur (Paris); 1962 Aug; 103():185-200. PubMed ID: 13863251
    [No Abstract]   [Full Text] [Related]  

  • 37. Antituberculous activity of isoniazid in combination with sulfisoxazole (Gantrisin). I. The effect of isoniazid-sulfisoxazole in vitro.
    NAITO M; WATANABE R; TSUKUMA S; IBA K
    Acta Tuberc Jpn; 1960 Sep; 10():47-56. PubMed ID: 13727549
    [No Abstract]   [Full Text] [Related]  

  • 38. [THE ROLE OF ACETYLATION IN THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID, AND ISONIAZID WITH PARA-AMINOBENZOIC ACID, IN PULMONARY TUBERCULOSIS].
    VITOLO A
    Bull Sci Med (Bologna); 1963; 135():396-402. PubMed ID: 14112984
    [No Abstract]   [Full Text] [Related]  

  • 39. The inhibition of isoniazid inactivation by means of PAS and benzoyl-PAS in man.
    LAUENER H; FAVEZ G
    Am Rev Respir Dis; 1959 Jul; 80(1, Part 1):26-37. PubMed ID: 13670386
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on double or triple resistance of Mycobacterium tuberculosis. 1. The rate of appearance of double or triple resistance, and the effect of drugs on the appearance of this resistance].
    KUROIWA K
    Kekkaku; 1960 Jul; 35():492-8. PubMed ID: 13755309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.